Back
State Street SPDR S&P Regional Banking ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
80
KRE
State Street SPDR S&P Regional Banking ETF
Last Price:
$67.48
Seasonality Move:
-0.22%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$78.95
Seasonality Move:
-32.16%
Buy
80
State Street SPDR S&P Regional Banking ETF (KRE)
is a Buy
Is State Street SPDR S&P Regional Banking ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P Regional Banking ETF [KRE] share price is $67.48. The Score for KRE is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
KRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KRE Stock Price Chart
What is State Street SPDR S&P Regional Banking ETF's stock price today?
-
The State Street SPDR S&P Regional Banking ETF share price today is $67.48Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRE is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.88The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
KRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.62 | Buy |
| Relative Strength Index (14 RSI): | 71.74 | Buy |
| Chaikin Money Flow: | -4347914 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.92 - 66.54) | Buy |
| Bollinger Bands (100): | (60.3 - 65.14) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -145421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.39 - 83.51) | Buy |
| Bollinger Bands (100): | (41.65 - 69.37) | Buy |
KRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.92 | Buy |
| 20-day SMA: | 64.7 | Buy |
| 50-day SMA: | 62.23 | Buy |
| 200-day SMA: | 60.02 | Buy |
| 8-day EMA: | 66.73 | Buy |
| 20-day EMA: | 65.09 | Buy |
| 50-day EMA: | 62.34 | Buy |
| 200-day EMA: | 39.73 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.2 | Sell |
| 20-day SMA: | 75.43 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 43.03 | Buy |
| 8-day EMA: | 83.79 | Sell |
| 20-day EMA: | 77.26 | Buy |
| 50-day EMA: | 67.4 | Buy |
| 200-day EMA: | 47.62 | Buy |
State Street SPDR S&P Regional Banking ETF Earnings Growth & KRE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
State Street SPDR S&P Regional Banking ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||